Attenuation of inflammatory response by 25- hydroxyvitamin D3-loaded polylactic acid microspheres in treatment of periodontitis in diabetic rats

Chin J Dent Res. 2014;17(2):91-8.

Abstract

Objective: To investigate the inhibitory effects of 25-hydroxyvitamin D3 (25(OH)D3)-loaded polylactic acid (PLA) microspheres on inflammatory response in diabetic periodontitis.

Methods: 25(OH)D3-loaded PLA microspheres were produced using emulsion-solvent evaporation method. Rat bone marrow stromal cells (BMSCs) cultured with Aggregatibacter actinomycetemcomitans in high glucose medium were chosen to mimic diabetic periodontitis. After cultivation with 25(OH)D3-loaded PLA microspheres, inflammation-related proteins in BMSCs were detected using Western blot analysis. Periodontitis was induced using silk ligatures in diabetic rats, and 25(OH)D3-loaded PLA microspheres were placed into the periodontal pockets. Periodontal tissues were examined using hematoxylin and eosin staining and western blot analysis.

Results: Drug release from the 25(OH)D3-loaded microspheres was relatively steady during 70 days. In a diabetic periodontitis-like environment, 25(OH)D3-loaded microspheres upregulated vitamin D receptor expression, and downregulated nuclear factor-κB expression and signal transducer and activator of transcription 3 phosphorylation in the BMSCs. These 25(OH)D3 microspheres also attenuated periodontal inflammatory infiltrate and bone loss in diabetic rats with periodontitis.

Conclusion: 25(OH)D3-loaded microspheres could ameliorate diabetic periodontitis by inhibiting inflammatory response, and may provide a potential therapy for patients with this disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Aggregatibacter actinomycetemcomitans / immunology
  • Alveolar Bone Loss / drug therapy
  • Alveolar Bone Loss / immunology
  • Animals
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use*
  • Calcifediol / administration & dosage
  • Calcifediol / therapeutic use*
  • Cell Culture Techniques
  • Cells, Cultured
  • Diabetes Mellitus, Experimental / complications*
  • Gingiva / immunology
  • Inflammation Mediators / analysis
  • Lactic Acid
  • Male
  • Mesenchymal Stem Cells / microbiology
  • Microspheres
  • NF-kappa B / analysis
  • Neutrophils / pathology
  • Periodontitis / drug therapy*
  • Periodontitis / immunology
  • Periodontitis / microbiology
  • Polyesters
  • Polymers
  • Rats
  • Rats, Wistar
  • Receptors, Calcitriol / analysis
  • STAT3 Transcription Factor / analysis
  • Streptozocin

Substances

  • Anti-Inflammatory Agents
  • Inflammation Mediators
  • NF-kappa B
  • Polyesters
  • Polymers
  • Receptors, Calcitriol
  • STAT3 Transcription Factor
  • Stat3 protein, rat
  • Lactic Acid
  • poly(lactide)
  • Streptozocin
  • Calcifediol